New urgency to update CDRH (Center for Devices and Radiological Health) guidance, FDA tells AdvaMed
This article was originally published in Clinica
The FDA's Center for Devices and Radiological Health is experimenting with ways to put more resources into the badly needed task of updating guidance documents, agency officials said at AdvaMed's 15th annual device submissions workshop.
You may also be interested in...
Dr Reddy's is poised to expand its OTC offering in Russia and certain CIS countries by snapping up a basket of allergy brands from India's Glenmark.
Second read-out maintains 94% level of efficacy, with a very early signal that it could outperform Pfizer’s rival mRNA candidate in preventing severe cases.
The French major and Regeneron have racked up another indication for Dupixent with the blockbuster getting approval in Europe to treat children with severe eczema.